10.63
price up icon6.07%   0.58
after-market 시간 외 거래: 10.61 -0.02 -0.19%
loading

Zevra Therapeutics Inc 주식(ZVRA)의 최신 뉴스

pulisher
May 04, 2026

MSN Money - MSN

May 04, 2026
pulisher
May 01, 2026

ZVRA Stock Price, Quote & Chart | ZEVRA THERAPEUTICS INC (NASDAQ:ZVRA) - ChartMill

May 01, 2026
pulisher
Apr 29, 2026

Zevra Therapeutics (ZVRA) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

Apr 29, 2026
pulisher
Apr 28, 2026

ZVRA Technical Analysis | Trend, Signals & Chart Patterns | ZEVRA THERAPEUTICS INC (NASDAQ:ZVRA) - ChartMill

Apr 28, 2026
pulisher
Apr 27, 2026

ZVRA stock soars on upbeat Q4 results, optimism for EMA approval of Niemann-Pick disease treatment - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Zevra Therapeutics announces CFO transition - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

Discipline and Rules-Based Execution in ZVRA Response - Stock Traders Daily

Apr 26, 2026
pulisher
Apr 26, 2026

Zevra Therapeutics rises amid takeover speculation - MSN

Apr 26, 2026
pulisher
Apr 23, 2026

Zevra Therapeutics gains amid takeover speculation - MSN

Apr 23, 2026
pulisher
Apr 22, 2026

Zevra Therapeutics schedules first quarter 2026 results release and webcast for May 6 - Traders Union

Apr 22, 2026
pulisher
Apr 22, 2026

Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call - The Globe and Mail

Apr 22, 2026
pulisher
Apr 22, 2026

Zevra to release first-quarter results after market close May 6 - Stock Titan

Apr 22, 2026
pulisher
Apr 20, 2026

ZEVRA THERAPEUTICS, INC. ($ZVRA) CEO 2025 Pay Revealed - Quiver Quantitative

Apr 20, 2026
pulisher
Apr 20, 2026

Zevra Therapeutics (ZVRA) Stock: End of Year (+0.52%) 2026-04-20Expert Verified Trades - Xã Vĩnh Công

Apr 20, 2026
pulisher
Apr 20, 2026

Board changes and rare-disease growth at Zevra (ZVRA) highlight 2026 proxy - Stock Titan

Apr 20, 2026
pulisher
Apr 16, 2026

Zevra Therapeutics to Engage Neurology Community at AANAM 2026 Booth in Chicago - Traders Union

Apr 16, 2026
pulisher
Apr 16, 2026

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 16, 2026
pulisher
Apr 15, 2026

Behavioral Patterns of ZVRA and Institutional Flows - Stock Traders Daily

Apr 15, 2026
pulisher
Apr 13, 2026

Short Squeeze: Will Zevra Therapeutics Inc benefit from geopolitical trendsMarket Performance Summary & Free Verified High Yield Trade Plans - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 12, 2026

Moving Averages: Can Zevra Therapeutics Inc maintain sales growth2026 Support & Resistance & AI Enhanced Execution Alerts - baoquankhu1.vn

Apr 12, 2026
pulisher
Apr 11, 2026

Zevra Therapeutics (NASDAQ:ZVRA) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Apr 11, 2026
pulisher
Apr 10, 2026

Is Zevra Therapeutics (ZVRA) Stock Safe to Buy Now | Price at $9.48, Down 2.37%High Attention Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Apr 10, 2026
pulisher
Apr 09, 2026

ZVRA SEC FilingsZevra Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 09, 2026
pulisher
Apr 09, 2026

Published on: 2026-04-10 05:39:10 - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 07, 2026

Returns Recap: Should I add Zevra Therapeutics Inc stock to my portfolioMarket Performance Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 07, 2026

Stratos Wealth Partners LTD. Boosts Stake in Zevra Therapeutics, Inc. $ZVRA - MarketBeat

Apr 07, 2026
pulisher
Apr 06, 2026

Zevra Therapeutics (NASDAQ: ZVRA) posts $106.5M 2025 revenue; proxy items - Stock Titan

Apr 06, 2026
pulisher
Apr 05, 2026

Zevra shares jump after selling SDX portfolio for $50M - MSN

Apr 05, 2026
pulisher
Apr 04, 2026

(ZVRA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Apr 04, 2026
pulisher
Apr 04, 2026

JPMorgan Chase & Co. Has $4.18 Million Stock Holdings in Zevra Therapeutics, Inc. $ZVRA - marketbeat.com

Apr 04, 2026
pulisher
Apr 03, 2026

Zevra Therapeutics Inc (1GDA.HM) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore

Apr 03, 2026
pulisher
Apr 03, 2026

ZVRA PE Ratio & Valuation, Is ZVRA Overvalued - Intellectia AI

Apr 03, 2026
pulisher
Apr 03, 2026

ZVRA Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai

Apr 03, 2026
pulisher
Apr 03, 2026

Hennion & Walsh Asset Management Inc. Invests $1.25 Million in Zevra Therapeutics, Inc. $ZVRA - MarketBeat

Apr 03, 2026
pulisher
Apr 02, 2026

Zevra Therapeutics Earnings Call Signals Profitable Turn - The Globe and Mail

Apr 02, 2026
pulisher
Apr 02, 2026

Zevra Therapeutics Inc (1GDA.HM) interactive stock chart - Yahoo Finance UK

Apr 02, 2026
pulisher
Apr 01, 2026

Sentiment Recap: Will Zevra Therapeutics Inc benefit from geopolitical trendsTrade Entry Report & Community Supported Trade Ideas - baoquankhu1.vn

Apr 01, 2026
pulisher
Apr 01, 2026

ZVRA Stock Analysis: Zevra Therapeutics Inc. biotech rises 2.36 percent to 9.54 - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 01, 2026
pulisher
Apr 01, 2026

Nio, Zevra Therapeutics, Vertex Pharmaceuticals and other big stocks moving higher on Tuesday - MSN

Apr 01, 2026
pulisher
Mar 31, 2026

Dividend Watch: Is Zevra Therapeutics Inc forming bullish engulfing patternsWeekly Risk Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn

Mar 31, 2026
$28.71
price up icon 1.94%
$50.59
price up icon 0.72%
$97.27
price down icon 1.54%
$139.32
price down icon 0.41%
$147.56
price down icon 0.12%
ONC ONC
$294.34
price down icon 0.90%
자본화:     |  볼륨(24시간):